← Open Payments lookup

MAKENA KELLY: Open Payments

NPI 1093306169 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,712 in 165 payments from 44 companies in 2025. Trend: 2023 $4,777 · 2024 $4,422 · 2025 $3,712

Food & beverage: $3,712
CompanyPaymentsAmount
Janssen Biotech, Inc.16$375
Novartis Pharmaceuticals Corporation22$324
Merck Sharp & Dohme LLC11$302
PFIZER INC.11$250
E.R. Squibb & Sons, L.L.C.12$204
ABBVIE INC.9$187
AstraZeneca Pharmaceuticals LP8$184
Incyte Corporation9$175
Lilly USA, LLC5$128
TerSera Therapeutics LLC4$118

Products named: KEYTRUDA, RYBREVANT, SCEMBLIX, OPDIVO, JAKAFI, VERZENIO, ERLEADA, IBRANCE.

Industry payments across ID — which companies pay providers there.